Skip to NavigationSkip to content

Pharmafile - Research and Development News

Alvotech has announced that it has begun a phase 1 study evaluating the safety, tolerability and pharmacokinetics of its golimumab biosimilar...
AbbVie and Amina Biotech have announced their collaboration for the discovery and development of mRNA biology modulators focusing on three oncology...
The FDA has approved US-based medical equipment supplier VERO Biotech’s new-generation tankless inhaled nitric oxide (iNO) delivery system. This new...
Day One Biopharmaceuticals is set to ask the FDA for approval for tovorafenib before the summer of 2023. Tovorafenib is Day One’s paediatric brain...
The FDA has approved Eisai and Biogen’s experimental antibody treatment lecanemab (also known as Leqembi) for the treatment of mild cognitive...
It is possible that Island Pharmaceuticals could begin its phase 2a PEACH clinical trial as soon as January 2023. The trial aims to assess its dengue...
US-based biotech companies Belharra Therapeutics and Genentech have announced a multi-year partnership to lead the discovery and development of small...
US-based Biogen and Alcyone Therapeutics have entered into a license and collaboration agreement to develop Alcyone’s ThecaFlex DRx™ System.
A new treatment option for adult and paediatric patients with a rare soft tissue cancer has been approved. The FDA has approved new immunotherapy...
Abiomed, a leading provider of medical technology focusing on the circulatory system and oxygenation, has announced that the FDA has approved its...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches